Tag Archives: Awareness

Stories & News

Mesothelioma Awareness Gets A Boost On Rare Disease Day 2013

Mesothelioma awareness fits the focus of  Rare Disease Day 2013

The fifth annual U.S. Rare Disease Day was held on February 28th.  Organized and supported by the National Organization for Rare Disorders (NORD), this event has been created to direct public attention on approximately 7,000 rare diseases that affect almost 30 million people in America.  And among the rare “orphaned” disorders is Mesothelioma, the  asbestos-related cancer disease which affects one-tenth of the American population.

Mesothelioma, NORD and Rare Disease DayOrphan disease status is assigned to any disease or disorder that fewer than 200,000 people in the United States.    Mesothelioma cancer, for example, has about 3,000 people in American that are diagnosed each year with the disease.   Rare Disease Day is an international advocacy day designated to raise public awareness of rare diseases, such as Mesothelioma,  and increase recognition globally with a concern solving rare disease effects.

According to NORD president and CEO, Peter Saltonsall, “There are nearly 30 million Americans—and millions more around the world—affected by rare diseases”

“Everyone knows someone with a rare disease. But, while many of these diseases are serious and lifelong, most have no treatment and many are not even being studied by researchers. This leaves patients and families without hope for a better future.”

Because mesothelioma is relative rare, as are other orphan diseases, managing this cancer and attempting to discover  appropriate treatment is sometimes overwhelming to the patient and their family.  And based on government statistics, orphan diseases are serious or life-threatening to  85-90 percent of patients, and still as few as 200 of theses diseases  like mesothelioma have any effective treatments currently.

Mesothelioma Cancer and the National Organization for Rare Disorders

This years conference theme for 2013 is global in focus, called  “Rare Disorders Without Borders.”   The day will have special significance for the United States since this year 2013 is the 30th anniversary of the congressional Orphan Drug Act.  Therefore, there are additional incentives that should encourage U.S. companies to develop treatments for rare diseases, as well as for  N.O.R.D. which was established in 1983 by advocates of patients with rare disorders like mesothelioma cancer.

N.O.R.D. set the 2013 program for Rare Disease Day to include activities in the U.S. that place a spotlight on awareness events at many  State Houses, a Rare Disease Research Hall of Fame, a Handprints Across America photo gallery, and an event at the National Institutes of Health (NIH) in Bethesda, MD.

Even after the passing of this special day, we still need your support and advocacy, so you still can get more information about Rare Disease Day activities for the United States at: www.rarediseaseday.us.  And additional information about global activities can be found at:  www.rarediseaseday.org.

MESOTHELIOMA DIAGNOSIS

Mesothelioma diagnosis typically begins with a sufferer’s visit to the doctor complaining of chronic chest pain. This pain is caused as a result of a buildup of fluid inside the pleural space; this is called pleural effusion and is the most common presenting symptom of malignant mesothelioma.malignant mesothelioma xray

Preliminary mesothelioma detection can be achieved through a chest imagery scan (CT scan, x-ray); however, mesothelioma is often misdiagnosed as viral pneumonia at this stage because of certain symptomatic similarities between the two. The only way to definitively verify a suspected case of malignant mesothelioma is through a biopsy.

A biopsy is a relatively minor procedure (dependent on the location of the tumor) during which a small section of suspect tissue is removed. The removed section is examined by a histopathologist, an expert in the study of diseased tissue. Histopathological examination can confirm a case of malignant mesothelioma while also typing and staging it. Understanding the type and stage can help doctors suggest the best of treatment.

You can also have your questions about malignant mesothelioma and clinical trials for new cures, answered for free by Dr. Gill at the Mesothelioma Research Foundation of America by clicking here: Ask Dr. Gill

Related articles
Meso Cancer

What Are The Stages of Mesothelioma Cancer Development?

Mesothelioma Cancer

One rare form of cancer is called Mesothelioma, a malignant tumor in the mesothelial tissues of the lungs and the abdomen, arising from the inhalation of asbestos. Because it is rare many people are unaware of this fatal disease. There are many people who go undiagnosed and die of Mesothelioma.  While there is a growing awareness of asbestos hazards  to health, too many people have not learned about Mesothelioma and therefore do not understand its cause, nature, signs and treatment. Today,  physicians find it difficult to detect Mesothelioma as its symptoms are similar to other lung diseases such as pneumonia and lung cancer. Moreover, it can take many years, decades, for a person exposed to asbestos to develop Mesothelioma.

Mesothelioma Awareness

Being unaware of Mesothelioma poses higher risks since it deters diagnosis and treatment. A person undergoing treatment must know the different stages of the cancer or the extent of the disease. Chances of recovering from Mesothelioma and the kind of treatment depend on the stage of the illness.

Mesothelioma Staging Systems

There are basically two staging systems used for Pleural Mesothelioma (lungs): TNM system and Brighan system. These staging systems are also used in other kinds of cancers; however, the first is commonly used. There is no established method in determining the stage of the Peritoneal Mesothelioma cancer (abdominal) so the TNM system is used.

The Mesothelioma TNM System

There are three variables in the TNM system: tumor, lymph nodes and metastasis. In the earliest stage of Mesothelioma, stage 1 (one), the malignant Mesothelioma cells start to grow and multiply only one layer of the pleura. The pleura is the membrane that encloses the lungs and lines the wall of the chest cavity. However, there are some instances wherein the pericardium (membrane that covers the heart) and diaphragm cover are already affected. In this case, the cancer patient is still in stage 1 (one) Mesothelioma.

In the second stage, the two layers of the pleura are already affected by Mesothelioma. Take note, however, that in this stage, only one side of the body is affected. Normally, the pleura produces only small amount of lubricating fluid that allows easy expanding and contracting of the lungs. The excess fluid is absorbed by the blood and the lymph vessels so there’s a balance between the amount of fluid produced and removed. During the second stage Mesothelioma, fluid starts to build up between the membrane of the lungs and the membrane of the chest wall, resulting to pleural effusion. The increase in the volume of fluid produced causes shortness of breath and chest pain. Other Mesothelioma cancer patients experience dry and persistent cough. Diagnosis of the pleural effusion is achieved through a chest x-ray.

Stage 3 (three) Mesothelioma means that the malignant cells have already spread to the chest wall, esophagus and the lymph nodes on one part of the chest. The patient may suffer severe pain near the parts affected. When not treated immediately or when the Mesothelioma patient doesn’t respond well to medication, the cancer may advance to the fourth stage.

Stage 4 (four) Mesothelioma is formidable since at this stage the Mesothelioma cells have penetrated into the bloodstream and other organs in the body like the liver, the bones and the brain. The lymph nodes on the other side of the chest may also be affected by Mesothelioma in stage 4 (four).

The Mesotheloma Brighan System

Brighan staging system, on the other hand, determines whether the Mesothelioma can be surgically removed or not and whether the lymph nodes are affected or not.

Stage 1 (one) Mesothelioma, the lymph nodes are not yet affected and the patient can still recover through surgery.

Stage 2 (two) Mesothelioma, surgery can still be executed but some lymph nodes have already been infiltrated by the cancer cells.

Stage 3 (three) Mesothelioma, the heart and chest wall are already affected; thus, surgery is no longer advisable. The lymph nodes in this stage, however, may or may not be affected.

Stage 4 (four) Mesothelioma, the final stage, cancer cells have already gone to the bloodstream and other parts of the body like the heart, brain, bone and liver. In most cases, a patient who has reached stage 4 (four) Mesothelioma only has four to twenty-four months to live.

Stories & News

A List of Studies on Mesothelioma and Chromosomal Abberrations

Study #1

Specificity of asbestos-induced chromosomal aberrations in short-term cultured human mesothelial cells

Cancer Genetics and Cytogenetics
Volume 41, Issue 1, August 1989, Pages 33-39
by Kenth Olofssona and Joachim Mark
Department of Pathology and Cytogenetics, Central Hospital, Skvde, Sweden

Abstract – Short-term cultured normal human mesothelial cells were exposed for 48 hours to three different asbestos compounds, crocidiolite, chrysotile, and amosite. In the concentration used (0.01 mg/ml) all three asbestiform minerals caused, within a few days, a significant increase of cells showing numerical and/or structural abnormalities. The abnormalities were analyzed in detail using banding techniques. The results were compared with the cytogenetic observations in 52 published cases of mesotheliomas. This comparison revealed only a few similarities as regards numerical deviations. The structural rearrangements in asbestos-exposed cultures, however, in many instances involved chromosome types and chromosome regions preferentially affected in mesotheliomas.

Study #2

Recovery of ingested asbestos fibers from the gastrointestinal lymph in rats

Environmental Research Volume 22, Issue 1, June 1980, Pages 201-216
by P. Sebastien, c, R. Masse, d and J. Bignon.

Abstract – Using the transmission electron microscope, asbestos fibers have been assessed in lymph fluid collected from the thoracic lymph duct in five groups of rats previously exposed to asbestos fibers (by ingestion). Ten rats were gavaged a single dose weighing approximately 20 mg. Five were given pure UICC chrysotile A while another group of five had pure UICC crocidolite. All the rats of the chrysotile group were positive animals with recovery rate values ranging from 6.9 107 to 3 105 (90% of the fibers being recovered during the first 16 hr following the gavage). The crocidolite group had only three positive animals and lower recovery rate values of 5.7 108 to 5.6 107. A third group was fed a synthetic diet containing 1%, by weight, chrysotile with a majority of short fibers (90% below 4 m). Of the 15 rats comprising this group, 13 were positive with maximum daily recovery rates ranging from 2.1 107 to 2.1 106. A group of eight rats fed the same kind of diet but containing a higher proportion of long fibers, showed only four positive animals, however, they had higher daily recovery rates ranging from 1.9 105 to 2.1 104. No fibers were encountered in the samples of the two control rats. This study demonstrates the passage of chrysotile and crocidolite fibers across the gastrointestinal wall, with the passage rate being higher for long fibers than short ones.

Study #3

Penetration of cells by asbestos fibers

Environ Health Perspect. 1974 December; 9: 255260
by J. M. G. Davis, R. E. Bolton, and J. Garrett

Abstract – Studies on the behavior of asbestos fibers within tissues have shown that the only cells that regularly contain asbestos are macrophages and their derivatives. However, these cells actively incorporate the asbestos fibers by the process of phagocytosis, and there is little evidence of direct penetration. Examination of the gut lining after prolonged asbestos ingestion has shown no evidence of dust penetration either through or between the epithelial cells. The structure and arrangement of these cells is discussed, and it is suggested that they are exceptionally well adapted to prevent penetration by any solid material.

Study #4

Static electrification of airborne asbestos: A study of its causes, assessment and effects on deposition in the lungs of rats

American Industrial Hygiene Association Journal, Volume 42, Issue 10 October 1981, pages 711 – 721
by J. H. Vincent; W. B. Johnston; A. D. Jones; A. M. Johnston

Abstract – The paper describes a series of experiments carried out in the laboratory to investigate how asbestos fibers might become electrostatically charged during the process of being made airborne, the magnitude and polarity of the charge per fiber, and the effect on lung deposition in rats. Measurements of the penetration of fibers through an electrostatic elutriator enabled the magnitude and distribution of charge in a cloud of fibers to be quantitatively assessed. Thus it was found that a typical fiber of UICC amosite, as dispersed in a typical animal exposure chamber, carried a net charge of magnitude equivalent to about 60 electrons. The distribution of charge was bimodal, suggesting that two charging mechanisms were taking place, the main one producing net negative charge and the lesser one producing net positive charge. These were attributed to materials in the dust dispenser used and with which the fibers came into contact during dispersal. It was found that the magnitude of charge on a typical fiber could be significantly reduced by the introduction of equal numbers of positive and negative gaseous ions from an a.c. corona discharge ionizer. Finally it was found that enhancement by up to 40% of the dust deposited into the slowest clearing part of the respiratory tract of experimental rats was brought about by the electrostatic charge on the airborne fibers. The implications of this finding in the field of occupational hygiene are briefly discussed.

Press Releases

Veglin Drug as Mesothelioma Treatment for Cancer Cure enters National Phase III Clinical Trials

Summary:

A new drug, Veglin, is a mesothelioma treatment that acts as like an anti-angiogenesis agent that works by cutting off the blood supply that cancer cells require in order to grow.  The cancer cells are starved with no adverse effects to normal healthy cells.  Clinical Trials of Veglin for Phase I and II have been successful at stopping mesothelioma cancer.  National clinical trials of this drug for Phase III study by FDA approval are ready to launch in 2011.

Mesothelioma Research Foundation of America
Westlake Village, California
March 24, 2011

Veglin is set for Phase III of the FDA approval process but we are currently being held back by the funding needed.  Good news is we are at the beginning of our fundraising season and hope to generate the funds needed over the next couple of months with clay shoots and golf tournaments taking place between may and July of 2011.

The benefit of introducing Veglin into Phase III is we will be able to provide Veglin to any facility of hospital willing to administer it to mesothelioma patients.  This will broaden our patient base and speed the FDA approval process in making Veglin a “mainstream” treatment for mesothelioma.  As of today we are very localized, administering the drug only in Southern California at the USC Norris Comprehensive Center, but we hope to have this changed very soon.

It is amazing how far we have come in the last 9 years, operating on a budget that is a fraction of what most pharmaceutical companies will put into the development of new drugs.  This is all thanks to our friends in the Insulators Unions, D.C. 16 and Building Trades Councils who are always there lending support.

About Veglin

Veglin is an anti-angiogenesis non-chemotherapy drug (angiogenesis inhibitor) that was developed by Dr. Parkash Gill’s for the treatment of a variety of malignancies including mesothelioma. Veglin is one of several newly developed non-chemotherapy drugs being tested for possible utilization in the ongoing struggle to combat malignant mesothelioma.

Veglin is an antisense oligonucleotide that binds with DNA genes that are responsible for the production of proteins called Vascular Endothelial Growth Factors (VEGF), with the intention of inhibiting their production. This new drug acts as like an anti-angiogenesis agent that works by cutting off the blood supply that cancer cells require in order to grow.  The cancer cells are starved with no adverse effects to normal healthy cells.

Veglin proved successful in FDA monitored Phase I and Phase II clinical trials.  Many patients suffering and dying from mesothelioma cancer are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims.

About Mesothelioma Research Foundation of America

The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill’s work created better treatment options. Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.

The Foundation began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.

Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill’s research.  Every dollar donated to the Foundation goes to the Phase III Clinical Trials of Veglin, a mesothelioma treatment.

Contact Information:

Shane Rucker
Mesothelioma Research Foundation of America
Toll Free:
(800) 909-Meso (6376)

Links:

Get their website information at:
http://mesorfa.org

Their blog is at:
http://mesorfa.info

Find them on FaceBook at:
http://facebook.mesorfa.org

Press Releases

National Asbestos Awareness Week with a New Hope for a Mesothelioma Treatment

National Asbestos Awareness Week will begin this year the first week of April.  Non-profit groups like the Mesothelioma Research Foundation of America (MesoRFA) and the Asbestos Disease Awareness Organization (ADAO) use this week to increase public awareness about the dangers of asbestos exposure and the mesothelioma treatments available for the cancer caused by asbestos particle inhalation.

On March 9, 2011, Senator Max Baucus (D-MT) and cosponsors introduced and passed US Senate Resolution 63 – 112th Congress.  This resolution (SR-63) designates the first week of April 2011 as National Asbestos Awareness Week. It urges the Surgeon General to warn and educate people about asbestos exposure, which may be hazardous to their health.  Senator Baucus began his crusade to abolish asbestos use in 1999 when he wrote a letter to then Secretary of Health and Human Services Donna Shalala requesting immediate medical help and assistance for his home state area of Libby, Montana.  Libby is a city that no one wants to live in because 1 in 8 residents has some kind of asbestos related ailments and estimates put the number of deaths related to asbestos mining at over 200.  The city once boomed from the mining of vermiculite (an asbestos containing mineral) but now it has a growing number of the town’ residents being sickened by asbestos released in the air.   The mine has been closed since 1990.

In 2002 EPA investigators found Libby, Montana to be contaminated with asbestos and began the process of containing the city.  The EPA attempted to declare a Public Health Emergency in Libby that was thwarted by the previous Federal Government Administration’s Office of Management and Budget.  Senator Baucus reported this failure in 2008, and on June 17, 2009, due in large part to Baucus’ reporting efforts, the EPA finally declared its first ever public health emergency in Libby, Montana.

Groups like MesoRFA and ADOA combine medical research, public and patient education, family advocacy and community support to compel a national and global rallying outcry for all nations to abolish asbestos mining and its use in manufactured products.  Additionally, the groups seek to increase public awareness of the suffering experienced by patients with mesothelioma with the hope to fund research and find the quickest cure to this cancer disease caused by exposure to asbestos.

Asbestos is a carcinogen to humans and exposure to it can cause diseases such as mesothelioma, lung cancer and asbestosis.  Research and studies from the World Health Organization (2004) provide estimates about asbestos-related disease from occupational exposure.  Their results counted 107,000 deaths and 1,523,000 DALYs where a Disability Adjusted Life Year (DALY) is defined as the measure of overall disease burden expressed as the number of years lost due to ill-health, disability or early death.  Other studies estimate during the next decade around the world there will be 300 deaths per day from asbestos related disease.

The ADOA will be having their 7th Annual Asbestos Awareness Conference (April 1 – 3, 2011 in Atlanta, Georgia) and will bring leading international experts together to discuss the impact of asbestos on public health, the environment, and the economy.   This organization seeks to give asbestos victims and concerned citizens a united voice to raise public awareness about the dangers of asbestos exposure. It is an independent global organization with a mission dedicated to stop asbestos use and preventing asbestos-related.

The MesoRFA compliments the ADOA objectives with their mission to fund medical research leading to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until recent research work created better options for mesothelioma treatments with the drug, Veglin. Today, the future looks very hopeful with improved treatment to those stricken by asbestos-caused mesothelioma cancer.

Many oncologists project the average post-diagnostic malignant mesothelioma survival time in sufferers is between one and two years. Also, traditional mesothelioma treatments have had no success in eradicating the disease and have produced limited success in extending a patient’s survival time. Therefore, new and experimental mesothelioma treatments have become increasingly popular as an option for cancer sufferers.

A new approach in finding a mesothelioma cure is a drug called Veglin being studied by Dr. Gill at the USC/Norris Comprehensive Cancer Center. Veglin is one of several newly developed non-chemotherapy drugs being tested in the ongoing struggle to combat malignant mesothelioma. The new drug is an anti-angiogenesis agent that works by cutting off the blood supply that cancer cells need in order to grow. Veglin is currently in the last part of Phase II Clinical Trials with the FDA and Phase III trials should begin sometime in 2011.  Mesothelioma sufferers interested in taking part in the next clinical trial should talk with their doctor, and are encouraged to contact Dr. Parkash Gill for more information on Veglin and the trials to be had nationally.

Everyone is encouraged to participate in the national observation of Asbestos Awareness Week.  Like the American Cancer Society, Senator Max Baucus (D-MT) and non-profit groups like the Mesothelioma Research Foundation of America (MesoRFA) and the Asbestos Disease Awareness Organization (ADAO), let us all use this week to increase public awareness about the dangers of asbestos exposure and available mesothelioma treatments, because everyone wants to see less cancer and more birthdays!

Stories & News

MesoRFA.org applauds the Zadroga Act passing a victory for 911 first responders dying from particulate dust inhalation

The James Zadroga 9/11 Health and Compensation Act passes the congress on Christmas Eve 2010.

Before Congress could leave for Christmas break this week, the Senate barely managed to pass a bill giving health benefits to the first responders that worked in the ruins left by the 911 attack, better known as Ground Zero.

While the results of this bill is only half the value Democrats has originally designed it to be, it was passed only because of the mass attention drawn to it in the last week by comedian Jon Stewart.  This bill has been lingering for years in various committees and for all practical purposes appeared dead last week.

Continue reading MesoRFA.org applauds the Zadroga Act passing a victory for 911 first responders dying from particulate dust inhalation →

Stories & News

Mesothelioma Awareness: High-Income National Government Exploits Vulnerable Developing Countries with Asbestos and a Time-Bomb of Deadly Disease.

The Mesothelioma Research Foundation of America along with the Canadian Medical Association, the International Ban Asbestos Secretariat (IBAS), and several other anti-asbestos campaigners are calling on the Quebec Government not to provide loan guarantees to a consortium who intend to restore Canada’s dying asbestos export industry.

Exposure to asbestos has proven since the 1960’s and 70’s to be the leading cause of a specific lung cancer called Mesothelioma.  Diagnosis of having this deadly disease is almost always a painful, death sentence.  For example, as the effects of asbestos on workers from the United Kingdom who were exposed in the 60’s and 70’s continue to manifest,  records show deaths from mesothelioma have increased from 895 in 1990 to 2,249 in 2008.  There is no indication of this declining, and this trend is beginning to be recognized in other high-income nations who used asbestos products including the United States.

Let our voice be heard and we ask you to join us in the call for Social Responsibility by all nations in supporting a ban on asbestos and its export.  (Click the LIKE and SHARE buttons on our web site, and let FaceBook tell-your-friends).

Continue reading Mesothelioma Awareness: High-Income National Government Exploits Vulnerable Developing Countries with Asbestos and a Time-Bomb of Deadly Disease. →

Meso Facts

How to prepare for your doctor visit to learn the most about Mesothelioma

It does not matter what you are seeing a doctor about, it could be your Mesothelioma or maybe something else, there are some things you can do to obtain the most information and benefit from your visit.

When you go to visit a doctor,  always have your part of the medical information ready. This would include a list of all medications you take, a history list of your medical problems, and identify the surgeries you may have had.   Always bring your copies of your health records including lab tests, x-ray films or scans if you have them; bring it all.  Sometimes, your visit to the doctor could become a meeting with many doctors, so with your help and records they can have more to know.

Tell your doctor if you know you have been exposed to Asbestos!

Before your appointment, prepare a list of questions for the doctor.  As these occur to you, write them down.  Do not be fearful of asking the Doctor these questions.  Bring a family member or close friend to the meeting with you if it will help you feel more at ease when asking questions.  Having another pair of ears to hear the Doctor’s reply to each question can also help you remember what was said.

When you are not certain about explanations, ask for more information or where you can get additional details.  Many times there are brochures provided freely with detailed simple explanations to help with understanding.  Some medical facilities also have educators that can help you.

Regarding information about Mesothelioma, lung cancer, and much more about contracting this deadly disease from asbestos exposure, you will find a wealth of answers at the Mesothelioma Research Foundation of America web site.

Here are some questions to get you started in making your list.  Also, review the reference links below to find more question examples:

  • What should I do if I need help after hours when the doctor’s business office is closed?
  • After hours, who do I need to contact and how?
  • Do I have all my prescriptions before leaving the doctor’s office?
    Should I make another appointment to visit again?  What date?
Related articles
Stories & News

A week to recognize valuable Allied Health Professionals who provide patient care to those with mesothelioma

National Allied Health Professionals Week starts November 7th with the purpose of raising public awareness and appreciation for the health care professions in the industry who are not doctors and nurses.  These dedicated individuals assist physicians and other members of your health care team in the professional delivery of your patient care services.  Allied health professionals also provide support in the prevention, identification and treatment of diseases such as mesothelioma.  There has been a multitude of people exposed to asbestos which is the primary cause of mesothelioma, a complex and rare disease.  And now there is an immediate need for a many more allied health professionals to provide appropriate levels of support to a rising population of mesothelioma patients.

Continue reading A week to recognize valuable Allied Health Professionals who provide patient care to those with mesothelioma →

Press Releases

Mesothelioma Day: the September 26th Resolution

Mesothelimoa Day — September 26, 2010

This year, MesoRFA produced a resolution for the nation and officially launched a campaign to raise national public awareness about mesothelioma cancer and the need of more financial support to fund the research for a cure.  There is so much more research to be completed and comparatively little support from the Government specifically for treatments and a cure to mesothelioma.  There just is not enough public awareness to get the Government’s focus on this issue.

Let us show you the numbers that highlight the urgent need to raise more money for mesothelioma research, which is the sole purpose of the Mesothelioma Research Foundation of America.

Join with us to help make your city government aware of Mesothelioma with its declaration in support of this special day.  You can facilitate this movement and make September 26, 2011 the greatest awareness day.   Here’s how: MesoRFA Resolution for Mesothelioma Awareness Day